title: Hormonal therapy for prostate cancer: current topics and future perspectives.
authors.forename: Hiroyoshi
authors.initials: H
authors.lastname: Suzuki
authors.forename: Shiro
authors.initials: S
authors.lastname: Hinotsu
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Akaza
authors.forename: Yasuhisa
authors.initials: Y
authors.lastname: Fujii
authors.forename: Satoru
authors.initials: S
authors.lastname: Kawakami
authors.forename: Kazunori
authors.initials: K
authors.lastname: Kihara
authors.forename: Koichiro
authors.initials: K
authors.lastname: Akakura
authors.forename: Motofumi
authors.initials: M
authors.lastname: Suzuki
authors.forename: Tadaichi
authors.initials: T
authors.lastname: Kitamura
authors.forename: Yukio
authors.initials: Y
authors.lastname: Homma
authors.forename: Atsushi
authors.initials: A
authors.lastname: Mizokami
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics; D000726:Androgen Antagonists / Q000627:therapeutic use*; D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D004961:Estramustine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D020641:Polymorphism, Single Nucleotide; D057285:Precision Medicine; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000235:genetics; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D004961:Estramustine